Hypomethylation of CYP2E1 and DUSP22 Promoters Associated With Disease Activity and Erosive Disease Among Rheumatoid Arthritis Patients.

Amanda MokBrooke RheadCalliope HolingueXiaorong ShaoHong L QuachDiana QuachElizabeth SinclairJonathan GrafJohn ImbodenThomas LinkRuby HarrisonVladimir ChernitskiyLisa F BarcellosLindsey A Criswell

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2018)

Methylation signatures specific to RA clinical outcomes may have utility as biomarkers or predictors of exposure, disease progression, and disease severity.

Keyphrases

disease activity
rheumatoid arthritis patients
rheumatoid arthritis
systemic lupus erythematosus
genome wide
ankylosing spondylitis
juvenile idiopathic arthritis
dna methylation
interstitial lung disease